Kao USA recalled Oribe Serene Scalp Densifying Shampoo on July 6 after discovering bacterial contamination in certain product lots [1, 2].
The recall is significant because the contamination poses a direct risk of bacterial infection to consumers using the luxury hair care product [1, 4].
Kao USA, the U.S. subsidiary of Kao Corporation, manages the Oribe brand and initiated the action after testing revealed the presence of harmful bacteria [1, 4]. The recall spans Canada and the United States, where the product was sold in 37 states [3, 5].
Reports on the retail cost of the affected shampoo vary by source. The New York Post said the retail price was $166 [1], while the International Business Times said the price was $52 [2].
Consumers are advised to check their product lots to determine if their shampoo is part of the affected batch. The company is working to remove the contaminated items from store shelves and distribution channels across North America [3, 5].
Because the product is designed for scalp treatment, the presence of bacteria is particularly concerning for those with sensitive skin or existing scalp conditions. The FDA has issued warnings regarding the nationwide nature of the recall [5].
“Bacterial contamination was detected in certain lots”
This recall highlights the vulnerability of high-end cosmetic supply chains to microbial contamination. Because the product is marketed for scalp densification, it is applied directly to the skin's surface, making any bacterial presence a potential public health risk rather than a simple quality control failure.
